Dongying Tiandong Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 2 molecules. Its filings concentrate with ARCSA (EC) and NCELS (KZ). Its GMP standing is certified by EMA and NCELS (KZ). Its most recent recorded inspection, by US FDA, closed on 19 October 2018 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| DONGYING, China | Not on file |
| Dongying City, China | Not on file |
| China, China | 3004395180 |
| Molecule | Regulators | Docs |
|---|---|---|
| Enoxaparin | EDQM, US FDA | 2 |
| Heparin Sodium | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 4 | None |
| NCELS (KZ) | 1 | 1 |
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Dongying Tiandong Pharmaceutical, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.